SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
6 Months Ended |
Jun. 30, 2016 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
|
Schedule of Concentration of Revenue and Geographic Area |
For the Three Months Ended June 30, 2016
|
|
For the Three Months Ended June 30, 2015
|
Licensor
|
|
License Amount
|
|
% of Revenue
|
|
Licensor
|
|
License Amount
|
|
% of Revenue
|
Dynamic Advances, LLC
|
|
$
|
24,900,000
|
|
72%
|
|
Sarif Biomedical LLC
|
|
$
|
325,000
|
|
24%
|
Orthophoenix, LLC
|
|
$
|
4,500,000
|
|
13%
|
|
Selene Communication Technologies, LLC
|
|
$
|
150,000
|
|
11%
|
Orthophoenix, LLC
|
|
$
|
3,750,000
|
|
11%
|
|
E2E Processing, Inc.
|
|
$
|
140,000
|
|
10%
|
Orthophoenix, LLC
|
|
$
|
600,000
|
|
2%
|
|
MedTech GmbH
|
|
$
|
131,420
|
|
9%
|
Signal IP, Inc.
|
|
$
|
310,000
|
|
1%
|
|
E2E Processing, Inc.
|
|
$
|
120,000
|
|
9%
|
|
|
Total
|
|
99%
|
|
|
|
Total
|
|
63%
|
|
Schedule of pending lawsuits against defendants |
As of June 30, 2016, the Company is involved in a total of 18 lawsuits against defendants in the following jurisdictions:
United States
|
|
|
District of Delaware
|
|
5
|
Central District of California
|
|
1
|
Eastern District of Michigan
|
|
1
|
US Court of Appeals for the Federal Circuit
|
|
2
|
|
|
|
Foreign
|
|
|
Germany
|
|
9
|
|
Schedule of computation of basic and diluted earnings (loss) per share |
|
|
For the Three Months Ended June 30, 2016
|
|
For the Three Months Ended June 30, 2015
|
|
For the Six Months Ended June 30, 2016
|
|
For the Six Months Ended June 30, 2015
|
Net income (loss) attributable to Marathon Patent Group, Inc. common shareholders
|
|
7,906,279
|
|
(4,502,696)
|
|
4,012,866
|
|
(9,284,267)
|
|
|
|
|
|
|
|
|
|
Denominator
|
|
|
|
|
|
|
|
|
Weighted Average Common Shares - Basic
|
|
14,994,697
|
|
13,998,563
|
|
14,980,919
|
|
13,937,872
|
Weighted Average Common Shares - Diluted
|
|
16,031,564
|
|
13,998,563
|
|
16,017,786
|
|
13,937,872
|
|
|
|
|
|
|
|
|
|
Earnings (Loss) per common share:
|
|
|
|
|
|
|
|
|
Income (Loss) - Basic
|
|
$
|
0.53
|
|
$
|
(0.32)
|
|
$
|
0.27
|
|
$
|
(0.67)
|
Income (Loss) - Diluted
|
|
$
|
0.49
|
|
$
|
(0.32)
|
|
$
|
0.25
|
|
$
|
(0.67)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|